SCHEMBL20031203

SCHEMBL20031203

CC(C)CNSS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6025541 0.71
SCHEMBL26431148 0.71 ADH1B (0.31)
SCHEMBL23543063 0.69
SCHEMBL25947565 0.69
SCHEMBL6025538 0.69
SCHEMBL21531775 0.69
SCHEMBL925857 0.67
SCHEMBL20097095 0.67 ADH1B (0.32)
SCHEMBL23521071 0.67
SCHEMBL22590249 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11856955-B2 Binary compositions as disruptors of Orco-mediated odorant sensing VANDERBILT UNIVERSITY (US) 2024-01-02 US disclosed
US-11814391-B2 Macrocyclic compounds for the treatment of medical disorders ACHILLION PHARMACEUTICALS, INC. (US) 2023-11-14 US disclosed
US-20200390099-A1 BINARY COMPOSITIONS AS DISRUPTORS OF ORCO-MEDIATED ODORANT SENSING UNIV VANDERBILT (US) 2020-12-17 US disclosed
US-20180094071-A1 ANTIGEN PRESENTING CELL TARGETED VACCINES BAYLOR RESEARCH INSTITUTE 2018-04-05 US disclosed